South Korean stock Bridge Biotherapeutics rose more than 20% today, with a market value of approximately US$36 million
-
币界网报道：On June 20, the stock price of Bridge Biotherapeutics, Inc., a listed biotechnology company in South Korea, rose by 20.59% today, and its market value rose to 49.218 billion Korean won, or approximately 36 million US dollars. Parataxis Holdings, an investment company previously focused on the digital asset field, announced that it has signed a final agreement with biotechnology company Bridge Biotherapeutics, Inc. to invest 25 billion Korean won to obtain a controlling stake in the company (the "Transaction"). After the transaction is completed, the company plans to change its company name to Parataxis Korea and continue to be listed on KOSDAQ.
下一篇
FUNToken Completes CertiK Audit, Smart Contract Permanently Freezes Supply to Achieve Deflation Design
- FUNToken announced that it has completed a comprehensive audit by CertiK. The smart contra...
208441